
Associate Principal Scientist (MSAT Expert Bioconjugates) @Lonzagroup. Former @royalsociety NIF @stjohnscam CRA/CTA @ChemCambridge. Views my own
Switzerland
Joined May 2019
- Tweets692
- Following1.6K
- Followers1.9K
- Likes4.2K
Travel with a baby is hard enough. At @LondonCityAir security they refused baby water/food, made me take off shoes/belt (while others didn’t), pulled apart the pram, and even put my BABY through extra scans. I’ve flown many airports with my baby, never over the top like this 😤
1
326
Barbara Bernardim retweeted
⭐ The Northern Lights over Cambridge!
📸 Dan Sayle for @stjohnscam; @cambridge_astro; @j_a_clarkson; @msdepieri.
#NorthernLights #AuroraBorealis #Cambridge
Zermatt live cameras from 10 pm to 1 am. On the right you can see the >4000 m peak Breithorn shining in bright pink 💜 I used these cameras to monitor when to go out (but my iPhone photos are sadly crap) #Auroraborealis #zermatt
Barbara Bernardim retweeted
'Cathepsin B Processing Is Required for the In Vivo Efficacy of Albumin–Drug Conjugates' from Bioconjugate Chemistry (@BioconjChem) is currently free to read as an #ACSEditorsChoice.
📖 Access the full article: go.acs.org/8cH
Barbara Bernardim retweeted
Check the latest work on albumin-drug conjugates! Great collaboration with Bernardes group. Well done Tuuli! pubs.acs.org/doi/full/10.102…
Barbara Bernardim retweeted
Application based on results from the TROPION-Lung01 phase 3 trial
If approved, datopotamab deruxtecan (dato-DXd) may be the first TROP2 directed antibody drug conjugate for patients with lung cancer
businesswire.com/news/home/2…
Barbara Bernardim retweeted
Today we announced two oral presentations at the upcoming @MDAorg Clinical & Scientific Conference on the initial data from our ACHIEVE and DELIVER clinical trials reported in Jan. 2024. Learn more: bit.ly/3SWo0G2 #MDAConference
It is not every day we can say something we synthesised works in mice 🧪🐭
Check out our latest contribution @BioconjChem #OpenAccess
Replying to @BioconjChem
🏅 Cathepsin B Processing Is Required for the In Vivo Efficacy of Albumin–Drug Conjugates
🖊 Barbara Bernardim et al @Cambridge_Uni and Universidade de Lisboa
Read for free ➡ go.acs.org/82l
Barbara Bernardim retweeted
We're thrilled to share our latest article in ACS-OL! In collaboration with Konig's lab, Kim and André have crafted a visible-light-induced, redox-neutral multicomponent reaction for the synthesis of succinamic acid derivatives in good yields. pubs.acs.org/doi/10.1021/acs…
Barbara Bernardim retweeted
Interesting review from Timman and Alcarazo @AlcarazoLab
α-Diazo-λ3-iodanes and α-diazo sulfonium salts: the umpolung of diazo compounds - now published in Chemical Communications pubs.rsc.org/en/content/arti…
Barbara Bernardim retweeted
Were you the first generation in your family to go to university? Would you like to do two years of further study @Cambridge_Uni?
You could be eligible for the John Crook Scholarship at St John's. Apply by 16 Oct 2023 via @ucas_online
Full details👉joh.cam.ac.uk/john-crook-sch…
Success without a successor is ultimately failure. Leaders become great not because of their power, but because of their ability to EMPOWER others ✨
16
1,518
Barbara Bernardim retweeted
Does your (EU) country attract or lose top researchers?
AT, CH attract a lot.
FR, DE, BE, ES are open places: as many leave as arrive.
IE is a closed system.
Italy, there is something very wrong: *very* few come, many go.
Plot made with @ERC_Research data.
Big congrats @BcbSousa 🤩
Delighted to share the preclinical studies of JS25, a selective BTK inhibitor, with potent efficacy in blood cancers relative to other BTK inhibitors used in the clinic. A special thank you to all the collaborators and to my supervisor @gbernardes_chem.
pubs.acs.org/doi/10.1021/acs…
1
5



























